The low-expression groups comprised a higher ratio of elderly patients, poorly differentiated tumors, and advanced stage (Figure 2C–E), suggesting that MAPK15 expression is involved in the carcinogenesis and progression of ovarian cancer. The gene discussed is MAPK15; the disease is ovarian cancer.